AI has not yet delivered on its promise to significantly impact cancer treatment, despite hopes that advanced algorithms could revolutionize drug discovery and development. Critics argue that the challenges in medicine are often rooted in economic incentives and a complex understanding of biology, rather than solely a lack of sophisticated AI. While AI can assist in identifying potential drug candidates, it currently struggles with the nuances of human biology and chemistry, highlighting the need for both systemic changes in drug development and more advanced AI capable of deeper reasoning. AI
RANK_REASON This is an opinion piece by a named credible voice discussing the limitations of current AI in healthcare.
- Dario Amodei
- David Ricks
- Eli Lilly
- Emilia Javorsky
- Future of Life Institute
- Gary Marcus
- Tanespimycin
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
